Receiving a semen analysis report for the first time can feel like reading a document in a foreign language. Volume, concentration, motility, morphology, total motile count — each parameter tells part of the story of sperm quality, and understanding what each one means helps you make informed decisions about ICI suitability and whether further investigation is needed.
Volume and Concentration
Ejaculate volume is the total amount of semen in a given sample, measured in milliliters. Normal volume is 1.4 mL or greater (WHO 2021 reference values). Volume below 1.4 mL (hypospermia) may indicate retrograde ejaculation (sperm entering the bladder instead of the urethra), ejaculatory duct obstruction, or low testosterone — all of which warrant urological evaluation. Abnormally high volume (above 6 mL) is less clinically significant but may dilute sperm concentration.
Sperm concentration is the number of sperm per milliliter of ejaculate, reported in millions per milliliter (million/mL). Normal concentration is 16 million/mL or greater. Oligospermia (low concentration) is classified as mild (10–16 million/mL), moderate (5–10 million/mL), or severe (below 5 million/mL). Azoospermia (no sperm in the ejaculate) is a distinct diagnosis requiring specialized evaluation. For ICI, which relies on sperm traveling through cervical mucus to reach the fallopian tubes, higher concentration is associated with better outcomes; concentrations below 16 million/mL suggest evaluating IUI with sperm wash as an alternative, since washing concentrates the motile fraction for direct uterine placement.
Motility: Total, Progressive, and Non-Progressive
Sperm motility describes the percentage of sperm that are moving, and it is subdivided into meaningful categories. Total motility (all moving sperm, including those moving in circles or twitching in place) should be above 42%. Progressive motility (sperm moving actively forward in a straight or large curved path) should be above 30%. Non-progressive motility (movement present but not forward-directed) is the remainder. For conception purposes, progressive motility is the most clinically relevant parameter because only progressively motile sperm can navigate the reproductive tract effectively.
Asthenospermia — low sperm motility — is the most common single semen analysis abnormality, present in approximately 37% of infertile men. Its causes range from oxidative stress and varicocele (surgical or lifestyle-treatable) to genetic abnormalities and anti-sperm antibodies (for which IUI or IVF with ICSI is the clinical pathway). For ICI, total motile count (concentration multiplied by total motility, multiplied by volume) is the most practically useful single number: a total motile count (TMC) above 20 million is generally considered adequate for ICI; 10–20 million is marginal; below 10 million is typically insufficient for ICI and warrants IUI or further evaluation.
Morphology: What Normal Sperm Look Like
Sperm morphology describes the percentage of sperm with normal shape. This is assessed using the Kruger strict criteria, which evaluates the head, midpiece, and tail of each sperm against precise shape standards. Normal morphology is defined as 4% or more by Kruger strict criteria — a threshold that seems surprisingly low but reflects the genuine rarity of perfectly formed sperm even in fertile men. Teratospermia (low morphology, below 4%) is associated with reduced fertilization rates, though its impact specifically on ICI — where thousands of sperm are competing for natural selection — is less dramatic than its impact on IVF-ICSI (where a single sperm is manually selected for injection).
Isolated teratospermia (low morphology with normal count and motility) has a relatively modest impact on ICI success compared to combined abnormalities. A man with normal count, good progressive motility, and morphology of 2–3% may still be a reasonable ICI candidate, particularly for initial cycles. The clinical decision to stay with ICI versus move to IUI is most influenced by total motile count rather than morphology alone, though combined abnormalities in count, motility, and morphology together produce a sufficiently low TMC that ICI is unlikely to succeed and IUI or IVF becomes the evidence-supported pathway.
Using Semen Analysis Results for Protocol Decisions
Translating semen analysis results into protocol decisions requires combining all parameters rather than reacting to any single abnormal value. A useful decision framework: if TMC is above 20 million and morphology is above 4%, ICI is an appropriate first-line approach. If TMC is 10–20 million or morphology is 2–4%, ICI may be attempted but IUI with sperm preparation is a reasonable alternative that concentrates the motile fraction for uterine placement. If TMC is below 10 million or multiple parameters are significantly abnormal, IUI with sperm wash is the more evidence-supported first step, and IVF-ICSI should be discussed if IUI cycles fail.
It is important to note that a single semen analysis has substantial intra-individual variability — the same man’s sample can differ dramatically based on abstinence interval, illness in the prior three months (fever particularly damages sperm quality), stress, hydration, and laboratory handling. ASRM recommends at least two semen analyses before making clinical decisions based on male factor findings, with samples collected 7 to 14 days apart. A second semen analysis that contradicts the first is clinically common and should be obtained before drawing strong conclusions from a single abnormal result.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the His Fertility Boost includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the MakeAmom His & Hers Kit includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: MakeAmom.com · Mosie.baby · IntracervicalInseminationKit.info
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.